Press "Enter" to skip to content

New patent for Janssen Biotech drug ZYTIGA

0
Copyright © DrugPatentWatch. Originally published at New patent for Janssen Biotech drug ZYTIGA

Annual Drug Patent Expirations for ZYTIGA
Annual Drug Patent Expirations for ZYTIGA

Zytiga is a drug marketed by Janssen Biotech and is included in one NDA. It is available from one supplier. There is one patent protecting this drug and two Paragraph IV challenges.

ZYTIGA drug price trends.

Drug patent litigation for ZYTIGA.

This drug has thirty-four patent family members in nineteen countries.

The generic ingredient in ZYTIGA is abiraterone acetate. One supplier is listed for this compound. Additional details are available on the abiraterone acetate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Janssen Biotech drug ZYTIGA
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions